Search

Organon & Co

Closed

SectorHealthcare

13.52 -0.29

Overview

Share price change

24h

Current

Min

13.52

Max

13.56

Key metrics

By Trading Economics

Income

351M

146M

Sales

-47M

1.5B

P/E

Sector Avg

14.505

62.58

EPS

0.71

Dividend yield

0.59

Profit margin

10

Employees

10,000

EBITDA

344M

409M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+3.24% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.59%

2.19%

Next Earnings

4 Aug 2026

Next Dividend date

10 Sept 2026

Next Ex Dividend date

14 Aug 2026

Market Stats

By TradingEconomics

Market Cap

87M

3.5B

Previous open

13.81

Previous close

13.52

News Sentiment

By Acuity

54%

46%

271 / 340 Healthcare

Organon & Co Chart

Past performance is not a reliable indicator of future results.

Related News

24 Jul 2026, 23:51 UTC

News

Tenet Healthcare reported second-quarter earnings of $6.12 per share, exceeding estimates. Shares are trading higher in after-market hours following the strong results.

24 Jul 2026, 23:46 UTC

News

HF Sinclair Corp has filed a lawsuit against the EPA over biofuel blending delays. Shares rose during after-market hours, maintaining a strong monthly performance.

24 Jul 2026, 23:41 UTC

News

Kinsale Capital Group reported Q2 earnings of $5.54 per share, exceeding estimates, with revenue of $548.5 million, driving shares higher in after-market trading.

24 Jul 2026, 23:41 UTC

Macro News
ETF Constituents
News

The Vanguard Information Technology ETF is higher in after-market hours, supported by key holdings like Apple and Qualcomm, despite broader market declines.

24 Jul 2026, 23:41 UTC

News

Datadog Inc. is higher in after-market trading, benefiting from steady quarter-over-quarter revenue growth despite being surpassed by CoreWeave in total revenue.

24 Jul 2026, 23:41 UTC

News

Boeing Co shares advanced in after-market hours, supported by a $695 billion backlog and positive analyst outlook on growth potential.

24 Jul 2026, 23:36 UTC

News

KKR & Co Inc shares are lower in after-market hours following a $238.954 million share sale, reflecting potential liquidity concerns and capital allocation shifts.

24 Jul 2026, 23:31 UTC

News

Interactive Brokers Group reported a 77% pre-tax profit margin but shares are lower in after-market hours amid concerns over rising interest rates and profitability.

24 Jul 2026, 23:21 UTC

News
Social Media

Micron Technology Inc shares are declining in after-market trading amid concerns over potential pricing pressures in the cyclical memory chip market.

24 Jul 2026, 23:21 UTC

Social Media
News

Warner Bros Discovery shares are lower in after-market trading as merger plans with Paramount Skydance are postponed until June 2027 amid legal challenges.

24 Jul 2026, 23:21 UTC

News

Baker Hughes Co shares rose in after-market hours after a decrease in the active rig count, which fell to 587, the lowest since mid-July.

24 Jul 2026, 23:16 UTC

News

CS PowerTech has launched its photovoltaic cell facility in Indiana, boosting Canadian Solar's U.S. manufacturing capabilities. Shares are higher in after-market trading.

24 Jul 2026, 23:16 UTC

News

Liberty Energy reported Q2 revenue of $1.19 billion, exceeding estimates. Shares are higher in after-market trading following the earnings release.

24 Jul 2026, 23:06 UTC

News

American Airlines Group Inc shares are lower in after-market hours following weaker profit guidance for the third quarter amid rising fuel costs.

24 Jul 2026, 23:01 UTC

ETF Constituents
News

Vanguard Growth ETF advances in after-market trading, supported by contributions from Apple, Uber, and Applied Materials, following three lower daily closes.

24 Jul 2026, 23:01 UTC

News

Elme Communities announced property sales totaling $294 million and revised liquidating distributions to $16.41 to $16.61 per share, trading higher in after-market hours.

24 Jul 2026, 23:01 UTC

News

CACI International Inc. shares declined in after-market trading, influenced by a downturn in the Research & Consulting Services sub-sector.

24 Jul 2026, 23:01 UTC

News

Emerson Electric Co shares are lower in after-market trading amid mixed market sentiment influenced by geopolitical tensions and new tariffs from the Trump administration.

24 Jul 2026, 23:01 UTC

News

Carrier Global Corp shares declined in after-market hours following the appointment of PTC's Neil Barua to its board, effective immediately.

24 Jul 2026, 23:01 UTC

News

Boston Scientific shares are higher in after-market hours despite a safety alert from the FDA regarding its ENROUTE Transcarotid Neuroprotection System catheters.

24 Jul 2026, 22:22 UTC

News
Social Media

Uber shares are higher in after-market hours amid intensifying discussions about its partnership with Waymo and potential regulatory moves in the autonomous vehicle sector.

24 Jul 2026, 22:02 UTC

News

ServiceNow shares are lower in after-market trading despite reporting $4 billion in revenue and raising full-year subscription guidance amid ongoing sector concerns.

24 Jul 2026, 22:01 UTC

News
Social Media

Booz Allen Hamilton reported Q1 fiscal 2027 adjusted EPS of $1.81, exceeding expectations, and provided optimistic revenue guidance, boosting shares higher in after-market hours.

24 Jul 2026, 21:41 UTC

News

Tractor Supply Co shares are lower in after-market hours, continuing a decline amid broader market volatility linked to geopolitical tensions and oil supply concerns.

24 Jul 2026, 21:31 UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

24 Jul 2026, 21:01 UTC

News

Golub Capital Bdc Inc reported a net asset value of $4.5 billion and is conducting a public offering of up to $10 billion in shares.

24 Jul 2026, 21:01 UTC

News

Hercules Capital Inc's shares are lower after the company closed a $325 million note offering, with proceeds for debt repayment and investments.

24 Jul 2026, 21:01 UTC

News

MetroCity Bankshares reported second-quarter net income of $22.1 million, missing expectations. Shares are higher in after-market trading, continuing a recent upward trend.

24 Jul 2026, 20:07 UTC

Social Media
Correlated Moves
News

iShares Core U.S. Aggregate Bond ETF is gaining as major indices rebound amid lower crude oil prices and inflation concerns. The ETF's yield is 4.99%.

24 Jul 2026, 20:07 UTC

News
Correlated Moves

Lovesac Co shares are lower as analysts express skepticism, citing slow revenue growth and weak free cash flow margins. The consensus price target is $24.17.

Peer Comparison

Price change

Organon & Co Forecast

Price Target

By TipRanks

3.24% upside

12 Months Forecast

Average 14 USD  3.24%

High 14 USD

Low 14 USD

Based on 2 Wall Street analysts offering 12 month price targets forOrganon & Co - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

2 ratings

0

Buy

2

Hold

0

Sell

Sentiment

By Acuity

271 / 340 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Organon & Co

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. It sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey.
help-icon Live chat